Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

VRCA

STRONG SELL

Verrica Pharmaceuticals Inc. · Healthcare · United States · $86M · Avg Vol: $210K/d

16
StockRank
Get insider-trade alerts
Q
38
V
29
M
30
P/E (TTM)
—
ROE
-72.3%
D/E
0.1x
Dividend %
—
Dir. Trades · 180d
None →
Buybacks · 180d
None →
Loading 1Y...
PRICE (1Y)-6.6%
5.025.485.936.396.84Jun 12Jul 7Jul 27
SMA 50SMA 200
Close
$5.35
RSI (14)
34.3
52W High
$9.82
From 52W High
0.5%

SCORE BREAKDOWN

Quality
38
ROIC
-39.5%19.1
ROE
-72.3%12.7
GP/Assets
48.5%86.6
Op. Margin
-193.4%14.3
FCF/Assets
-25.8%13.9
Piotroski
239.0
Int. Cover
-2.1x32.7
D/E Ratio
0.09x64.4
Current Ratio
2.10x39.5
Value
29
P/E (TTM)
—N/A
EV/EBITDA
-5.1x25.0
P/FCF
—N/A
P/B
5.4x25.2
P/S
2.3x63.4
Div Yield
—N/A
Momentum
30
52W High %
54%31.7
RS 6M
-39%23.0
SMA 50/200
0.99x61.5
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
-13%16.7
Q Growth
—N/A

FUNDAMENTALS

Market Cap
$86M
P/E (Forward)
-4.0x
Gross Margin
61.5%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of VRCA are excluded.

TickerCompanyMkt CapStockRankSignal
VRCAVerrica Pharmaceuticals Inc.(you)$86M16STRONG SELL
BDTXBlack Diamond Therapeutics, Inc.$101M16STRONG SELL
OSTXOS Therapies Incorporated$68M16STRONG SELL
COYACoya Therapeutics, Inc.$100M13STRONG SELL
ACRVAcrivon Therapeutics, Inc.$68M14STRONG SELL
MAIAMAIA Biotechnology, Inc.$75M12STRONG SELL
TELOTelomir Pharmaceuticals, Inc.$79M11STRONG SELL
BMEABiomea Fusion, Inc.$90M10STRONG SELL
MNOVMediciNova, Inc.$65M14STRONG SELL
PLRXPliant Therapeutics, Inc.$67M18STRONG SELL

Peer medians: ROE -25.5% · P/E 27.6x · Gross margin 50.5%

Verrica Pharmaceuticals Inc. (VRCA) — Stock Score Summary

Verrica Pharmaceuticals Inc. (VRCA) has a MoatMap StockRank of 16/100 based on Quality (38/100), Value (29/100), and Momentum (30/100) factor scores. The current signal is STRONG SELL.

Key Financial Metrics

Price$5.35
Market Cap$86M
P/E (Forward)-4.04
Price/Book5.37
Return on Equity-72.3%
Return on Invested Capital-39.5%
Debt/Equity0.09x
Gross Margin61.5%
Operating Margin-193.4%
Revenue Growth46.1%
Free Cash Flow$-12M

Verrica Pharmaceuticals Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Verrica Pharmaceuticals Inc.’s (VRCA) StockRank?
MoatMap’s StockRank for Verrica Pharmaceuticals Inc. (VRCA) is 16/100, with a Strong Sell signal. It is a composite of Quality (38), Value (29), and Momentum (30) factor ranks across MoatMap’s 20,000+ stock universe.
Does Verrica Pharmaceuticals Inc. have an economic moat?
Verrica Pharmaceuticals Inc. (VRCA) has a Quality factor score of 38/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Verrica Pharmaceuticals Inc. a buy, hold, or sell?
MoatMap’s current signal for Verrica Pharmaceuticals Inc. (VRCA) is Strong Sell, based on a StockRank of 16/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Verrica Pharmaceuticals Inc. in?
Verrica Pharmaceuticals Inc. (VRCA) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksVRCA deep dive reportAI ChampionsHow we score stocksSense-check another stock